© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Pamela L. Kunz, MD, discusses classifying neuroendocrine tumors (NETs) and the potential to predict response.
Pamela L. Kunz, MD, assistant professor, Division of Oncology, Stanford University School of Medicine, discusses classifying neuroendocrine tumors (NETs) and the potential to predict response.
<<<
Back to the Gastrointestinal Cancers Symposium conference page